AstraZeneca | Investor Event Presentation Deck | 55 slides · page 34 of 55
The slide uses a market segmentation approach to map clinical trials (NIAGARA, POTOMAC, VOLGA, NILE) to patient populations (NMIBC, MIBC, 1L mUC).
Conference presentation · problem_statement · diagnose_problem · overcrowded density
Slide locked Sign in to view
Slide schematic 8/8
callout 1/1 diagram 1/1 list 1/1 metric 1/1 paragraph 1/1 source-note 1/1 table 1/1 title 1/1
Components 8
primary process bullet big-number paragraph source-note data headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1